Trial intelligence / Profile preview

NHSAB: Hypertonic Saline and Salbutamol in Acute Bronchiolitis

NCT02760719Phase 2Terminated

Sponsor
University Medical Centre Ljubljana
Start
Dec 2015
Primary completion
Jul 2019
Modality
Small Molecules, Device-based Delivery
Countries
1
01

Overview

Phase 2, randomised, open-label trial of hypertonic saline in bronchiolitis (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Fit to discharge time. Started Dec 2015; status: terminated.

02

Drugs

hypertonic saline
03

Conditions

bronchiolitis

Beyond the preview

Go deeper on NCT02760719.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02760719.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call